Your selection
Research, Innovation, Patient care, Education / 18.09.2025
Talk in the Cube: IP STRATEGIES IN BIOTECHNOLOGY
We are excited to continue the Talks in the Cube with an expert discussion focused on Strategies for Intellectual Property Rights in Biotechnology.
Effective strategies for Intellectual Property (IP) in Biotechnology include using patents for new processes and products, applying trade secrets for complex bioengineering methods, and employing trademarks for branding. A comprehensive strategy also means building adequate patent portfolios through patent jungles or "Biobetters", monitoring and defending IP rights against infringement, and potentially using licensing agreements for technology transfer.
Our two esteemed experts who are trained natural scientists AND European Patent Attorneys. They will share their insights and experiences with us.
A Panel Discussion with
Dr. Sun Jin Lee, European Patent Attorney, European Patent Litigator (UPC), Maiwald GmbH, Munich
Dr. Oliver Ladendorf, LL.B., European Patent Attorney, Kraus & Lederer PartGmbH, Munich
Dr. Uwe Lohmeier, Berlin BioScience Academy (BBA), Campus Berlin Buch GmbH (Moderation).
Topics planned to be addressed
- Smart patenting for Biotech: Portfolios providing leverage and attracting investors
- Licensing of innovative technologies: Patents for organoids and CRISPR/Cas
- Biotech Patents and AI: Examples to influence innovations and to protect data-driven discoveries.
The talk will be followed by a networking event where you can socialize over snacks and drinks.
Target audience
Founders & scientists from start-ups, small and medium-sized life science companies and scientific institutions.
Costs
Participation is free of charge. Registration is requested.
When
Thursday, 18 September 2025
5:00 p.m. - 7:00 p.m.
Where
BerlinBioCube (Building D95), Campus Berlin-Buch, Robert-Rössle-Straße 10, 13125 Berlin
Quelle: BerlinBioscience Academy
Further information and registration
Overview News
News Buch Berlin
A new opportunity for Berlin
The Einstein Center for Early Disease Interception has been funded with six million euros. In an interview, Nikolaus Rajewsky and Leif Erik Sander, both spokespeople of the center, explain why new tec...
more ...A spin-off targeting neuromuscular disorders
A team led by Mina Gouti has developed a stem cell-based model that enables researchers to test new drugs to treat neuromuscular diseases and to refine existing therapies. The project, called NMJCare,...
more ...What determines the fate of a T cell?
Researchers at the Max Delbrück Center have found that a cellular housekeeping mechanism called autophagy plays a major role in ensuring that T stem cells undergo normal cell division. The findings, p...
more ...Events Buch Berlin
20.03.2026, 08:45
Einladung: UniStem Day für Berliner Schülerinnen und Schüler aus Biokursen
Das German Stem Cell Network (GSCN) lädt die an Biologie interessierten Berliner Schülerinnen und Schüler (Biologie-Leistungskurse und Grundkurse) mit ihren Lehrkräften herzlich zum UniStem Day – zum ...
more ...22.09.2026, 09:00
GMP Biotech Summer School
Knowing and applying the Good Manufacturing Practice (GMP) regulations is one of the key elements in the manufacture of medicinal products for clinical trials and on an industrial level.
more ...
